Cyn-K Bio
Cyn-K Bio is a Kyoto University-originated bioventure focused on developing next-generation pharmaceuticals for healthy longevity and anti-aging. The company aims to solve the challenges of an aging society by developing innovative drugs that target cellular aging, which is linked to various diseases like Alzheimer's, diabetes, and arteriosclerosis. Their development strategy centers around antibody drugs and therapeutic vaccines, particularly utilizing VLP vaccine technology for its high efficacy and adaptability. Cyn-K Bio leverages AI, IoT, and blockchain for ultra-efficient drug discovery and personalized medicine, striving to reduce development time and cost. Their mission is to realize a healthy longevity society by extending healthspan.
Cyn-K Bio
Cyn-K Bio is a Kyoto University-originated bioventure focused on developing next-generation pharmaceuticals for healthy longevity and anti-aging. The company aims to solve the challenges of an aging society by developing innovative drugs that target cellular aging, which is linked to various diseases like Alzheimer's, diabetes, and arteriosclerosis. Their development strategy centers around antibody drugs and therapeutic vaccines, particularly utilizing VLP vaccine technology for its high efficacy and adaptability. Cyn-K Bio leverages AI, IoT, and blockchain for ultra-efficient drug discovery and personalized medicine, striving to reduce development time and cost. Their mission is to realize a healthy longevity society by extending healthspan.